Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Tetra Bio-Pharma (TBPMF)

Tetra Bio-Pharma (TBPMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Tetra Bio-Pharma Announces Listing to OTCPink Market PR Newswire - Fri Feb 10, 2023

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Announces Listing to OTCPink Market Newswire.ca - Fri Feb 10, 2023

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
REDUVO™ Marketing Approval on the Right Path PR Newswire - Thu Dec 22, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
REDUVO™ Marketing Approval on the Right Path Newswire.ca - Thu Dec 22, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir PR Newswire - Tue Dec 6, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir Newswire.ca - Tue Dec 6, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 PR Newswire - Tue Nov 29, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 Newswire.ca - Tue Nov 29, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission PR Newswire - Fri Nov 18, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission Newswire.ca - Fri Nov 18, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)

Barchart Exclusives

Dividend Aristocrats: The Best of the Best for Stable Income Barchart - 1 hour ago
Dividend Aristocrats' ability to increase their dividends indicates strong earnings and a solid business foundation, which lowers investment risk. Moreover, their consistent earnings growth often enables them to outperform broader market indices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot